AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

4Mineta SR 500 Tablet

Prescription Icon
Prescription Required

Marketer

Aneta pharmaceuticals Pvt. Ltd

Salt Composition

Metformin (500mg)

Overview 4Mineta SR 500 Tablet

Metformin 500mg Extended-Release tablets manage type 2 diabetes by regulating blood glucose, mitigating associated complications. This medication also addresses Polycystic Ovary Syndrome (PCOS) in women. For optimal absorption and reduced gastrointestinal upset, take with food, consistently at the same time daily. Discontinue only under physician guidance. Dietary adherence and exercise, as prescribed, are crucial for effective diabetes control alongside medication. Common side effects may include diarrhea, nausea, vomiting, gas, fatigue, indigestion, stomach discomfort, headache, and decreased appetite. Concurrent use with other diabetes medications, alcohol, or missed meals raises hypoglycemia risk; regular blood sugar monitoring is vital. Prior to initiating treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require physician consultation. Kidney function assessment precedes treatment. Limit alcohol consumption to minimize potential side effects.

Primary Ingredients of 4Mineta SR 500 Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of 4Mineta SR 500 Tablet

Managing type 2 diabetes and polycystic ovary syndrome (PCOS)

Major Benefits of 4Mineta SR 500 Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the 4Mineta SR 500 Tablet with a meal.

Common Side effects of 4Mineta SR 500 Tablet:

  • Diarrhea
  • Headache
  • Vomiting
  • Nausea
  • Flatulence
  • Abdominal discomfort
  • Weakness

How to use 4Mineta SR 500 Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume 4Mineta SR 500 Tablet with a meal.

How 4Mineta SR 500 Tablet works:

Metformin extended-release 500 mg tablets are a biguanide class anti-diabetic drug. Their mechanism involves reducing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and 4Mineta SR 500 Tablets poses a safety risk.

PregnancyPregnancySAFE IF PRESCRIBED

Use of 4Mineta SR 500 Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, data from human trials are scarce.

Breast feedingBreast feedingCAUTION

Use of Mineta SR 500mg tablets requires careful consideration while breastfeeding. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use 4Mineta SR 500 Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. However, 4Mineta SR 500 Tablets are contraindicated in individuals with severely compromised kidney function.

LiverLiverUNSAFE

The use of 4Mineta SR 500 Tablets is contraindicated in individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take 4Mineta SR 500 Tablet :

Should you forget a dose of 4Mineta SR 500 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About 4Mineta SR 500 Tablet

LabelValue
Type of Compound Guanidine-based compound
Potential for Dependence None.
Treatment Category Medication for diabetes

FAQs on 4Mineta SR 500 Tablet

Individuals with type 2 diabetes exhibit impaired responsiveness to endogenous insulin. This results in elevated blood glucose concentrations. 4Mineta SR 500 Tablet employs a multi-faceted approach to lower these elevated blood sugar levels. It reduces hepatic glucose production, diminishes postprandial intestinal glucose absorption, and enhances insulin sensitivity in peripheral tissues. These actions facilitate improved glucose uptake from the bloodstream and augment the body's natural insulin response.
Indeed, clinical trials indicate that 4Mineta SR 500 Tablets can lead to weight reduction in overweight or obese patients. This weight loss effect may also be observed, albeit less significantly, in overweight or obese individuals predisposed to diabetes. Furthermore, individuals with insulin resistance or sensitivity may experience weight reduction. However, self-initiation of this medication for weight management is strongly discouraged. Always seek medical advice before commencing treatment.
Metformin extended-release 500 mg is an initial treatment option for hyperglycemia. This medication manages blood glucose by enhancing insulin sensitivity, reducing hepatic glucose production, and lessening intestinal glucose absorption. Differing from other oral hypoglycemics, monotherapy with metformin extended-release 500 mg infrequently results in hypoglycemia due to its mechanism that avoids excessive insulin secretion. Beyond glycemic control, it also aids in weight management.
4Mineta SR 500 tablets generally don't induce drowsiness and are typically well-received. Infrequently, though, this medication can lead to sleep disturbances and insomnia. Drowsiness might indicate a severe adverse reaction known as lactic acidosis, especially prevalent in individuals with impaired kidney function. Consult your physician immediately if fatigue or sleepiness develops during treatment with 4Mineta SR 500 tablets.
Administer one 4Mineta SR 500mg tablet, or more as directed by your physician, with or following a meal. The tablets should be swallowed whole with water; do not crush or chew them. For once-daily prescriptions, take the tablet in the morning with breakfast. For twice-daily prescriptions, divide the dose, taking one tablet with breakfast and the other with dinner. If three doses are prescribed, take the third tablet with lunch. Ingesting 4Mineta SR 500mg tablets with food may mitigate gastrointestinal distress, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals diagnosed with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to endogenous insulin. This leads to elevated blood glucose concentrations. 4Mineta SR 500 Tablet works through multiple mechanisms to lower these high blood sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption following meals, and enhances insulin sensitivity in tissues. These actions facilitate improved glucose uptake from the bloodstream and augment the body's natural insulin response.
Individuals overweight or obese taking 4Mineta SR 500 Tablets have experienced weight reduction. This effect may also be observed in overweight or obese individuals predisposed to diabetes. Furthermore, weight loss can occur in patients with insulin sensitivity or resistance. However, self-medicating with this drug for weight loss is inadvisable; physician consultation is necessary.
Metformin extended-release 500 mg is an initial treatment option for individuals with elevated blood glucose. This medication aids in blood sugar regulation by enhancing the body's insulin sensitivity, reducing hepatic glucose production, and minimizing intestinal glucose absorption. Differing from other oral hypoglycemics, Metformin extended-release 500 mg monotherapy infrequently leads to hypoglycemia due to its mechanism that avoids excessive insulin release. Beyond glycemic control, this medication also contributes to weight management.
4Mineta SR 500 Tablets generally don't induce drowsiness and are typically well-received. Infrequently, though, this medication might lead to sleep disturbances or insomnia. Excessive sleepiness could signal a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Consult your physician immediately if fatigue or somnolence develops during treatment with 4Mineta SR 500 Tablets.
Administer one 4Mineta SR 500mg tablet with or following a meal. The tablet should be swallowed whole with water; do not crush or chew. For once-daily prescriptions, take the tablet in the morning with breakfast. Twice-daily prescriptions should be divided, one with breakfast and one with dinner. For thrice-daily regimens, distribute doses with breakfast, lunch, and dinner. Consuming 4Mineta SR 500mg tablets with food mitigates potential gastrointestinal distress such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their own insulin. This results in elevated blood glucose levels. 4Mineta SR 500 Tablet works through multiple mechanisms to lower these elevated sugar levels. It reduces glucose generation by the liver, diminishes glucose absorption from the intestines following meals, and enhances the insulin sensitivity of bodily tissues. This combined action facilitates improved glucose uptake from the bloodstream. The tablet also promotes a more effective response to naturally produced insulin.
Weight loss has been observed in overweight and obese individuals using 4Mineta SR 500 Tablets. A slight weight reduction may also occur in overweight and obese patients predisposed to diabetes, as well as those with insulin sensitivity or resistance. However, self-medicating with this drug for weight management is inadvisable; physician consultation is necessary.
Metformin extended-release 500 mg is an initial treatment option for individuals with elevated blood glucose. This medication manages blood sugar by enhancing the body's sensitivity to pancreatic insulin, reducing hepatic glucose production, and diminishing intestinal glucose absorption. Unlike other oral hypoglycemics, metformin extended-release 500 mg monotherapy infrequently leads to hypoglycemia due to its mechanism of action that avoids excessive insulin secretion. Beyond glycemic control, it also aids in weight management.
Minet SR 500mg tablets generally do not induce drowsiness and are typically well-received. Infrequently, though, Minet SR 500mg tablets may lead to sleep disturbances or insomnia. Drowsiness can be a symptom of a severe adverse reaction known as lactic acidosis, especially prevalent in individuals with impaired kidney function. Seek medical advice if fatigue or sleepiness develops during treatment with Minet SR 500mg tablets.
Administer one 4Mineta SR 500mg tablet with or following a meal. The tablet should be swallowed whole with water; do not crush or chew. For once-daily regimens, take the tablet in the morning with breakfast. Twice-daily prescriptions should be divided, one dose with breakfast and the other with dinner. If three doses are prescribed, administer one with each meal (breakfast, lunch, and dinner). Consuming 4Mineta SR 500mg tablets with food helps mitigate potential gastrointestinal discomfort, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
4Mineta SR 500 Tablet
22
MRP 25
12% off